abemaciclib
eli lilly
['bcsm', 'monarch', 'breast']
join us at #asco22, where we ll be presenting on factors increasing the rate of treatment discontinuations in the monarche trial. view presentation details here: #earlybreastcancer #bcsm 
US healthcare providers’ home for emerging science from Lilly Oncology and Loxo Oncology at Lilly. Please see our community guidelines: https://t.co/1q8vAe63mK